C irCumferential cervical fusion is indicated for various pathologies, including deformity, myelopathy, infection, and tumor. The two most common indications for surgery are cervical spondylotic myelopathy (CSM) and cervical osteomyelitis (COM). The treatment of patients with COM can be challenging, as these patients often have additional comorbidities. We set out to compare circumferential cervical fusion in patients with COM versus in those with CSM to identify differences in perioperative morbidity and mortality. We hypothesized that the number of complications, hospital readmissions, and mortalities would be higher in the COM group. A comparison of COM with CSM has not been done to delineate the perioperative risk profile of these two patient groups.
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Methods
The University of California, San Francisco, institutional review board on cervical pathology approved the protocol for this retrospective study. We searched our institutional database for consecutive cases of CSM and COM treated with circumferential cervical fusion performed by two senior surgeons (P.V.M. and D.C.) during the same time period (2005) (2006) (2007) (2008) (2009) (2010) (2011) (2012) (2013) .
Indications for surgery for COM included pathological fractures, myelopathy, and failure of antibiotic therapy. Indications for surgery in the CSM group included myelopathy and kyphosis. In both groups, multilevel anterior corpectomy was an indication for posterior fusion. For those who had one-level anterior corpectomy, significant kyphotic deformity or osteoporosis was an indication for circumferential fusion. Indications for circumferential fusion in the CSM group for the most part included significant kyphotic deformity or poor bone stock. Indications for circumferential fusion in the COM group included kyphotic deformity and the need for anterior or posterior access to an infectious process.
We analyzed the number of levels of corpectomies, use of allograft versus autograft, and use of cages (titanium or polyetheretherketone [PEEK] cage). Furthermore, the estimated blood loss (EBL), perioperative complications, short-and long-term mortality, and change in postoperative Nurick grade were compared. Perioperative complications were analyzed, including renal failure, pneumonia, wound infection, deltoid palsy, and CSF leakage.
The Fisher exact test was used for categorical outcomes, and the Student t-test was used for continuous outcomes. The SAS 9.3 software (SAS Institute Inc.) was used for statistical analysis.
Results

Clinical Data
Our cohort included 24 patients with CSM and 22 with COM. Patient ages ranged from 20 to 73 years old, and the average age overall was 54.1 years. The average age in the COM group was 51.9 years, versus 56.1 years in the CSM group, and the two cohorts showed no significant differences in age (p = 0.171; Table 1 ). Most patients in the COM group were male (17 [77.3%] of 22 patients), and most in the CSM group were female (15 [62.5%] of 24 patients). Comorbidities included kidney disease, liver disease, chronic obstructive pulmonary disease, stroke, hypertension, diabetes mellitus, heart disease, and hyperlipidemia. Differences in these comorbidities between the two patient groups were not statistically significant except in the presence of liver disease. The number of anterior levels fused ranged between 1 and 4, and the difference between the two patient groups was not statistically significant (p = 0.287; Table 2 ). However, use of an autograft and the type of cage used were significantly different between the groups (p < 0.001 for both). The EBL was a mean of 1083.3 ml in the COM group and 363.8 ml in the CSM group (p = 0.070). The length of stay (LOS) in days was significantly different between the two groups: 13.9 days for the COM group versus 8.5 days for the CSM group (p < 0.001).
The timing of surgery in the CSM group was on average 101.13 days from the onset of symptoms. Timing of surgery in the COM group was on average 10.45 days from the onset of symptoms. The difference between these two groups was statistically significant (p = 0.011). The percentage of patients with improvement in their postoperative Nurick grades in the COM group was less than that in the CSM group (9.1% vs 62.5%, respectively, p < 0.001; Table 3 ). Among those presenting to surgery within 25 days of symptom onset, 80% of CSM patients had improved Nurick grades, whereas 9.5% of those with COM had improved Nurick grades (p < 0.001). Table 4 shows the infectious pathogens harbored by patients in the COM group.
Follow-Up
Patients were followed up at routine intervals in the clinic. In the event that patients were unable to return to the clinic, a telephone follow-up was performed; this type of follow-up was done in only 2 patients in the COM group and 1 in the CSM group. The length of follow-up was not statistically different between the two groups: 32.9 months for the COM group and 20.0 months for the CSM group (p = 0.058). The COM group tended not to return for follow-up and frequently skipped follow-up visits. We lost to follow-up 5 patients in the COM group and 2 in the CSM group.
Complications
We analyzed complications including direct surgical and perioperative systemic complications. The 30-day reoperation rates were not different between the two groups (p = 0.605). Perioperative complications occurred in 12 of 22 patients in the COM group and 8 of 24 in the CSM group (p = 0.147). The 30-day mortality rate was 0 in both groups (p = 0.999), and the 30-day readmission rate was 9% (2 of 22 patients) in the COM group and 12% (3 of 24 patients) in the CSM group (p = 0.710). The overall death rate at the final follow-up was higher in the COM group than in the CSM group (18.8% vs 4.5%, p = 0.159). There was one case of wound infection and washout in the COM group, which did not require reinstrumentation 
Discussion
Spinal osteomyelitis makes up 1%-7% of osseous infections. 13 The incidence of spinal infection is estimated at 1 case per 100,000 persons.
1 Forty percent to 80% of cases involve Staphylococcus aureus. 2, 4 Early recognition and diagnosis of spinal osteomyelitis is essential to prevent kyphotic deformity and neurological injury. Prior to the advent of antibiotics, approximately 40%-70% of patients with spinal infections died. 14 Currently, intravenous followed by oral antibiotics are generally indicated when there is no neurological compromise. Antibiotics should be started as soon as tissue is obtained for culture. 2 Bracing may also be considered in this group, along with close clinical and radiographic follow-up. Surgery is indicated when there is neurological compromise, instability, or deformity of the spine and when antibiotics fail to control infection. 5 The principles of surgical treatment in this subgroup of patients include removal of infected tissue, restoration of neurological function, correction of deformity, and spinal stabilization (Fig. 1). 14 Surgical treatment options include anterior decompression often with corpectomy followed by cage placement and fusion and/or posterior decompression with fusion depending on the location of the purulent material. If more than 3 levels are fused anteriorly, then we typically also perform posterior fusion to increase fusion rates. 7 There is some evidence to support titanium hardware as the least likely to harbor bacteria that can cause reinfection. In a series of 88 cases of vertebral osteomyelitis treated with titanium cages, Ruf et al. showed that none had reinfection. 12 On the other hand, Mondorf et al. have shown the successful use of PEEK cages in cervical ventral fusion in spondylodiscitis. 6 In vertebral osteomyelitis patients, major complications have been reported to be as high as 33%; and death rates, as high as 33%. 3, [8] [9] [10] [11] Compared with thoracic and lumbar osteomyelitis, COM is rare. 5 In this study we present one of the largest groups with COM (22 patients) thus far.
Morbidity and mortality are often high in the COM group of patients, as many are plagued with bacteremia, end-stage renal disease, immunocompromised status, and intravenous drug abuse.
Among patients who had undergone circumferential fusions, we set out to compare perioperative morbidity and mortality in those with CSM and those with COM. Our goal was to generate data that could be used in the informed consent process for patients with CSM (Fig. 2) or COM undergoing cervical surgeries to give a more targeted assessment of risks for different populations undergoing similar surgeries.
Our results show that our groups of consecutive CSM and COM patients were well matched except for sex and preoperative liver disease (cirrhosis). There were no significant differences in the number of levels fused. The type of cage used for COM versus CSM was different, as we tended to use titanium in infected cases, as suggested by Ruf et al. 12 Although EBL was not significantly different between the groups, there was a noticeable trend for greater EBL in the COM group versus that in the CSM group (1083.3 vs 363.8 ml). We think that this is because patients with COM are more prone to hemorrhage due to friable and inflamed tissue. Perioperative complications were higher in the COM group as well; however, the difference between the two groups was not statistically significant. The 30-day readmission was not significantly different between the groups. The LOS was significantly longer for the COM group, which can probably be explained by the need to place a tunneled intravenous line and transfer the patient to a skilled nursing facility. Interestingly, the overall death rate at the final follow-up was trending higher in the COM group (18.8% vs 4.5% in the CSM group, p = 0.159). Neurological improvement in the COM patients was statistically less significant than for CSM patients.
The major study limitation was sample size. Circumferential cervical fusions are relatively rare. Note also that 5 patients in the COM group and 2 in the CSM group were lost to follow-up after hospital discharge. Unfortunately, this study may have been too underpowered to show significant differences in perioperative morbidity and mortality.
Conclusions
Circumferential cervical fusion in patients with COM has trends for higher morbidity and mortality as compared with those in patients who underwent similar procedures to treat CSM. Furthermore, the COM patients had less neurological recovery than the CSM patients. This information may be useful in the informed consent process for both groups of patients. 
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